| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 10 4857-4867, Copyright © 1997 by American Association of Immunologists
ARTICLES |
DS Ramer-Quinn, RA Baker and VM Sanders
Department of Cell Biology, Neurobiology, and Anatomy, Loyola University Medical Center, Maywood, IL 60153, USA.
We recently reported that resting clones of murine Th1 cells, but not resting Th2 cells, expressed a detectable level of the beta-2- adrenergic receptor (beta 2AR). In the present study, we proposed that the level of beta 2AR expression on anti-CD3 mAb-activated CD4+ effector Th cells may differ from the level on resting cells, and that a change in receptor expression may alter the functional responsiveness of these cells to either the beta 2AR-selective ligand terbutaline or the sympathetic neurotransmitter norepinephrine. Following anti-CD3 activation, the beta 2AR was expressed on Th1 cells, but not Th2 cells. The number of binding sites on Th1 cells was maintained, with no change in affinity, over a 24-h activation period. When Th clones were exposed to terbutaline following anti-CD3 activation, Th1 cell, but not Th2 cell, cytokine production was modulated. IL-2 production by Th1 cells was decreased, while IFN-gamma production was not significantly altered. The decrease in IL-2 production was concentration dependent and was blocked by an antagonist. In comparison with control supernatants, the lower level of IL-2 present in terbutaline-exposed culture supernatants supported the proliferation of an IL-2-dependent Th1 clone to a lesser degree. Additionally, norepinephrine down- modulates IL-2, but not IFN-gamma, production by binding specifically to the beta-adrenergic receptor. Thus, a detectable level of the beta 2AR is expressed on activated Th1 cells, but not activated Th2 cells, thereby providing a mechanism by which IL-2 production is preferentially modulated by an endogenous and therapeutic ligand following Th1 cell activation.
This article has been cited by other articles:
|
|
 |
|
  Y. Kannan-Hayashi, K. Okamura, S. Hattori, M. Kuwamura, E. Higuchi, H. Terayama, M. Moriyama, M. Mukamoto, M. Okada, Y. Ohsugi, et al. Neuritogenic Effects of T Cell-Derived IL-3 on Mouse Splenic Sympathetic Neurons In Vivo J. Immunol., March 15, 2008; 180(6): 4227 - 4234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kern and T. Ziemssen Review: Brain immune communication psychoneuroimmunology of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21. [Abstract] [PDF]
|
|
|
|
|
|
R. T. Emeny, D. Gao, and D. A. Lawrence beta1-Adrenergic Receptors on Immune Cells Impair Innate Defenses against Listeria J. Immunol., April 15, 2007; 178(8): 4876 - 4884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Gong, U. Pleyer, K. Vogt, I. Anegon, A. Flugel, H.-D. Volk, and T. Ritter Local Overexpression of Nerve Growth Factor in Rat Corneal Transplants Improves Allograft Survival Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1043 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cosentino, A. M. Fietta, M. Ferrari, E. Rasini, R. Bombelli, E. Carcano, F. Saporiti, F. Meloni, F. Marino, and S. Lecchini Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop Blood, January 15, 2007; 109(2): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Kin and V. M. Sanders It takes nerve to tell T and B cells what to do J. Leukoc. Biol., June 1, 2006; 79(6): 1093 - 1104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. de Salamanca, K. F. Siemasko, Y. Diebold, M. Calonge, J. Gao, M. Juarez-Campo, and M. E. Stern Expression of Muscarinic and Adrenergic Receptors in Normal Human Conjunctival Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 504 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Deng, K. Muthu, R. Gamelli, R. Shankar, and S. B. Jones Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis Am J Physiol Cell Physiol, September 1, 2004; 287(3): C730 - C736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Kohut, J. R. Thompson, W. Lee, and J. E. Cunnick Exercise training-induced adaptations of immune response are mediated by {beta}-adrenergic receptors in aged but not young mice J Appl Physiol, April 1, 2004; 96(4): 1312 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miura, T. Kudo, A. Matsuki, K. Sekikawa, Y.-I. Tagawa, Y. Iwakura, and A. Nakane Effect of 6-Hydroxydopamine on Host Resistance against Listeria monocytogenes Infection Infect. Immun., December 1, 2001; 69(12): 7234 - 7241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Kohm and V. M. Sanders Norepinephrine and beta 2-Adrenergic Receptor Stimulation Regulate CD4+ T and B Lymphocyte Function in Vitro and in Vivo Pharmacol. Rev., December 1, 2001; 53(4): 487 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Lombardi, A. Kavelaars, P. M. Cobelens, R. E. Schmidt, M. Schedlowski, and C. J. Heijnen Adjuvant Arthritis Induces Down-Regulation of G Protein-Coupled Receptor Kinases in the Immune System J. Immunol., February 1, 2001; 166(3): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Swanson, W. T. Lee, and V. M. Sanders IFN-{{gamma}} Production by Th1 Cells Generated from Naive CD4+ T Cells Exposed to Norepinephrine J. Immunol., January 1, 2001; 166(1): 232 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Kasprowicz, A. P. Kohm, M. T. Berton, A. J. Chruscinski, A. Sharpe, and V. M. Sanders Stimulation of the B Cell Receptor, CD86 (B7-2), and the {beta}2-Adrenergic Receptor Intrinsically Modulates the Level of IgG1 and IgE Produced per B Cell J. Immunol., July 15, 2000; 165(2): 680 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Kohm, Y. Tang2, V. M. Sanders, and S. B. Jones3 Activation of Antigen-Specific CD4+ Th2 Cells and B Cells In Vivo Increases Norepinephrine Release in the Spleen and Bone Marrow J. Immunol., July 15, 2000; 165(2): 725 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. P. Karalis, E. Kontopoulos, L. J. Muglia, and J. A. Majzoub Corticotropin-releasing hormone deficiency unmasks the proinflammatory effect of epinephrine PNAS, June 8, 1999; 96(12): 7093 - 7097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Malfait, A. S. Malik, L. Marinova-Mutafchieva, D. M. Butler, R. N. Maini, and M. Feldmann The {beta}2-Adrenergic Agonist Salbutamol Is a Potent Suppressor of Established Collagen-Induced Arthritis: Mechanisms of Action J. Immunol., May 15, 1999; 162(10): 6278 - 6283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Kohm and V. M. Sanders Suppression of Antigen-Specific Th2 Cell-Dependent IgM and IgG1 Production Following Norepinephrine Depletion In Vivo J. Immunol., May 1, 1999; 162(9): 5299 - 5308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Alaniz, S. A. Thomas, M. Perez-Melgosa, K. Mueller, A. G. Farr, R. D. Palmiter, and C. B. Wilson Dopamine beta -hydroxylase deficiency impairs cellular immunity PNAS, March 2, 1999; 96(5): 2274 - 2278. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
